A Phase ½ Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination with Epacadostat (INCB 24360) in Subjects with Selected Cancers

Type of Cancer
Unknown

Sponsor
Incyte

Protocol Number
24360-202:

To Learn More Call
201-510-0910